What is the causes and risk factors of Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that occurs when the
body's immune system attacks its own tissues, particularly the synovial membrane
that lines the joints, leading to joint pain, stiffness, and swelling. The exact cause of
RA is not known, but several factors can increase the risk of developing the condition.
These include:

1. Genetics: Genetics plays an important role in the development of rheumatoid

arthritis (RA). While the exact genetic factors that contribute to RA are not fully
understood, researchers believe that multiple genes are involved. Studies have
shown that people with a family history of RA have an increased risk of
developing the condition.

There are certain genetic markers, known as human leukocyte antigens (HLAs),
that are associated with RA. HLAs are proteins that help the immune system
distinguish between self and foreign substances. Some HLAs may increase the
risk of developing RA, while others may offer some protection.

The most common HLA associated with RA is HLA-DRB1, specifically the

subset called HLA-DRB1*04. This subset is found in about two-thirds of people
with RA. Other HLA genes, including HLA-DPB1, HLA-DQB1, and HLA-
DRB4, have also been associated with RA.

However, having these genetic markers does not guarantee that a person will
develop RA, as many people with these markers never develop the condition. In
fact, only a small proportion of people with the HLA-DRB1*04 subset will
develop RA. Other genetic and environmental factors are likely involved in the
development of the condition.

2. Environmental factors: Environmental factors have also been shown to play a role
in the development of rheumatoid arthritis (RA). Exposure to certain
environmental triggers can activate the immune system and lead to the
development of RA in people who are genetically susceptible to the condition.
Some of the environmental factors that have been linked to RA include:

- Smoking: Smoking is one of the most well-established environmental risk

factors for RA. Studies have shown that smokers have a higher risk of
 developing RA than non-smokers, and that the risk increases with the amount
of smoking.

- Infections: Infections, particularly those caused by certain bacteria and

viruses, have been linked to the development of RA. This is thought to occur
because the infection triggers an immune response that can lead to
inflammation and joint damage.
- Diet: Some studies suggest that certain dietary factors may increase the risk of
RA, such as a high intake of red meat, sugar, and saturated fats. Other studies
have suggested that a diet rich in omega-3 fatty acids and antioxidants may
have a protective effect against RA.
- Hormonal factors: Some environmental factors, such as hormonal changes
during pregnancy and menopause, have been linked to the development of
RA. This may be because hormonal changes can affect the immune system
and contribute to inflammation.

3. Pollution: Pollution, specifically exposure to certain environmental pollutants, has

been linked to the development of rheumatoid arthritis (RA). Air pollution and
heavy metal exposure are two types of pollutants that have been shown to be
associated with an increased risk of RA.

Air pollution, particularly fine particulate matter (PM), is a complex mixture of

solid and liquid particles that can come from a variety of sources, including
traffic, industry, and burning of fossil fuels. Studies have found that people living
in areas with high levels of air pollution are more likely to develop RA than those
living in areas with low levels of air pollution. The risk appears to be highest for
people who have been exposed to air pollution for a long time, such as those
living near highways or in industrial areas.

Heavy metals, such as cadmium, lead, and mercury, are toxic substances that can
accumulate in the body over time. Exposure to heavy metals can occur through
contaminated food and water, industrial processes, and smoking. Studies have
shown that people with RA tend to have higher levels of heavy metals in their
blood and urine than people without RA. It is believed that heavy metal exposure
can trigger an immune response that leads to inflammation and joint damage.
Nevertheless, reducing exposure to environmental pollutants, such as by avoiding
areas with high levels of air pollution and minimizing exposure to heavy metals,
may help to reduce the risk of developing RA.
4. Hormones: Hormonal factors have been implicated in the development of
rheumatoid arthritis (RA). RA is much more common in women than in men, and
the onset of the disease in women often occurs after hormonal changes such as
pregnancy and menopause. These observations suggest that hormones may play a
role in the development of RA.

Estrogen is one hormone that has been studied in relation to RA. Estrogen has
anti-inflammatory properties and is thought to help protect against inflammation
and joint damage. However, the relationship between estrogen and RA is complex,
as the effects of estrogen can vary depending on the context. For example, during
pregnancy, estrogen levels are high, and many women with RA experience an
improvement in their symptoms. In contrast, during menopause, when estrogen
levels decline, some women may experience an increase in RA symptoms.

Other hormones, such as prolactin and testosterone, may also play a role in the
development of RA. Prolactin is a hormone that stimulates the production of
breast milk in women, but it is also involved in the immune system and
inflammation. Studies have shown that women with RA have higher levels of
prolactin than women without RA, and that blocking prolactin can improve RA
symptoms.

Testosterone, which is more prevalent in men than women, has anti-inflammatory

properties and is thought to offer some protection against RA. Men are less likely
to develop RA than women, and men with RA tend to have less severe symptoms
than women with RA.

5. Age: Age is a significant risk factor for the development of rheumatoid arthritis
(RA). While RA can occur at any age, it is most commonly diagnosed in people
between the ages of 40 and 60. The prevalence of RA increases with age, with up
to 3% of people over the age of 60 being affected by the disease.

The reasons for the age-related increase in RA risk are not fully understood, but it
is believed that age-related changes in the immune system and other physiological
processes may contribute to the development of the disease. As we age, our
immune system becomes less effective at fighting off infections and other
challenges, which may make us more susceptible to developing autoimmune
conditions like RA. Additionally, age-related changes in bone and joint structure
 may increase the risk of joint damage in people with RA.

Another factor that may contribute to the age-related increase in RA risk is the
accumulation of other risk factors over time. For example, exposure to
environmental pollutants or certain infections may increase the risk of developing
RA, and these exposures may accumulate over time. Similarly, unhealthy lifestyle
habits, such as a poor diet or smoking, may increase the risk of RA and may
become more prevalent with age.

6. Obesity: Obesity is a risk factor for the development of rheumatoid arthritis (RA).
Multiple studies have shown a strong association between obesity and an
increased risk of developing RA, and people with obesity are more likely to have
more severe and progressive disease.

The exact mechanisms by which obesity increases the risk of RA are not fully
understood, but it is believed that the chronic low-grade inflammation that
accompanies obesity may play a role. Obesity is characterized by a state of
chronic inflammation, and the excess fat tissue produces cytokines and adipokines
that can promote inflammation throughout the body. This inflammation can affect
joint tissues and contribute to the development of RA.

In addition to contributing to the development of RA, obesity can also exacerbate

the symptoms of the disease. People with obesity and RA are more likely to
experience joint pain, stiffness, and functional limitations than those who are not
overweight.

Weight loss has been shown to be effective in reducing inflammation and

improving symptoms in people with RA. In fact, weight loss is recommended as a
part of the standard treatment for RA. Losing weight can help to reduce the
overall burden on the joints and improve joint function, which can help to improve
quality of life.

7. Lifestyle factors: Lifestyle factors can play a significant role in the development
of rheumatoid arthritis (RA). Some of the lifestyle factors that have been linked to
the development of RA include:

- Smoking: Smoking is a well-established risk factor for RA. Studies have

shown that people who smoke are more likely to develop RA than non-
 smokers, and that the risk increases with the number of cigarettes smoked.
- Alcohol consumption: Heavy alcohol consumption has been linked to an
increased risk of RA, although the relationship is not as clear as it is with
smoking.
- Physical activity: Regular physical activity has been shown to have a
protective effect against the development of RA. It is thought that exercise
helps to reduce inflammation and improve joint function.
- Stress: Chronic stress has been linked to an increased risk of RA, although the
relationship is not fully understood. It is thought that stress may affect the
immune system and increase inflammation, which can contribute to the
development of the disease.
- Sleep: Poor sleep quality has been linked to an increased risk of RA, as well as
to more severe symptoms in people with the disease. It is thought that sleep
disturbances can increase inflammation and affect the immune system.
- Occupation: Certain occupations, such as those that involve repetitive motion
or exposure to environmental pollutants, have been linked to an increased risk
of RA.
- Diet: As mentioned earlier, certain dietary factors may contribute to the
development and progression of RA. A healthy and balanced diet that is rich in
anti-inflammatory foods may help to reduce the risk of developing RA and
may also help to manage symptoms in people with the disease.

References:
1. Akdemir, G., Heimans, L., Bergstra, S. A., Goekoop, R., Van Oosterhout,

M., Van Groenendael, J. H. L. M., Peeters, A., Steup-Beekman, G. M.,

Lard, L., De Sonnaville, P. B. J., Grillet, B., Huizinga, T. W. J., &

Allaart, C. F. (2018). Clinical and radiological outcomes of 5-year drug-

free remission-steered treatment in patients with early arthritis:

IMPROVED study. Annals of the Rheumatic Diseases, 77(1), 111–118.

https://doi.org/10.1136/annrheumdis-2017-211375
2. Alamanos, Y., & Drosos, A. A. (2005). Epidemiology of adult

rheumatoid arthritis. Autoimmunity Reviews, 4(3), 130–136.

https://doi.org/10.1016/j.autrev.2004.09.002

3. Chapman, B., & Moynihan, J. A. (2009). The brain–skin connection: role

of psychosocial factors and neuropeptides in psoriasis. Expert Review of

Clinical Immunology, 5(6), 623–627. https://doi.org/10.1586/eci.09.56

4. Congress Passes Landmark Legislation Restricting Restraints &

Seclusion | NAMI: National Alliance on Mental Illness. (2000).

https://www.nami.org/Press-Media/Press-Releases/2000/Congress-

Passes-Landmark-Legislation-Restricting

5. Ferucci, E. D., Choromanski, T. L., Varney, D. T., Ryan, H. F.,

Townshend-Bulson, L., McMahon, B. J., & Wener, M. H. (2017).

Prevalence and correlates of hepatitis C virus–associated inflammatory

arthritis in a population-based cohort. Seminars in Arthritis and

Rheumatism. https://doi.org/10.1016/j.semarthrit.2017.04.004

6. Giles, J. T., Ling, S. M., Ferrucci, L., Bartlett, S. J., Andersen, R. E.,

Towns, M. C., Muller, D. C., Fontaine, K. R., & Bathon, J. M. (2008).

Abnormal body composition phenotypes in older rheumatoid arthritis

patients: Association with disease characteristics and pharmacotherapies.

 Arthritis & Rheumatism, 59(6), 807–815.

https://doi.org/10.1002/art.23719

7. McInnes, I. B., & Schett, G. (2011). The Pathogenesis of Rheumatoid

Arthritis. The New England Journal of Medicine, 365(23), 2205–2219.

https://doi.org/10.1056/nejmra1004965

8. Oliver, J. E., & Silman, A. J. (2006). Risk factors for the development of

rheumatoid arthritis. Scandinavian Journal of Rheumatology, 35(3), 169–

174. https://doi.org/10.1080/03009740600718080

9. Silman, A. J., & Pearson, J. (2002). Epidemiology and genetics of

rheumatoid arthritis. Arthritis Research, 4(Suppl 3), S265.

https://doi.org/10.1186/ar578

10. Ummarino, D. (2017). Rheumatic disease after immune checkpoint

inhibitor therapy. Nature Reviews Rheumatology.

https://doi.org/10.1038/nrrheum.2017.113